Bill Text: NJ A425 | 2024-2025 | Regular Session | Introduced
Bill Title: Requires long-term care facilities to stock and provide COVID-19 antiviral treatments to residents.
Spectrum: Partisan Bill (Republican 2-0)
Status: (Introduced) 2024-01-09 - Introduced, Referred to Assembly Health Committee [A425 Detail]
Download: New_Jersey-2024-A425-Introduced.html
STATE OF NEW JERSEY
221st LEGISLATURE
PRE-FILED FOR INTRODUCTION IN THE 2024 SESSION
Sponsored by:
Assemblyman ROBERT AUTH
District 39 (Bergen and Passaic)
Co-Sponsored by:
Assemblywoman Flynn
SYNOPSIS
Requires long-term care facilities to stock and provide COVID-19 antiviral treatments to residents.
CURRENT VERSION OF TEXT
Introduced Pending Technical Review by Legislative Counsel.
An Act concerning COVID-19 antiviral treatments in long-term care facilities and supplementing Title 26 of the Revised Statutes.
Be It Enacted by the Senate and General Assembly of the State of New Jersey:
1. a. Each long-term care facility shall maintain an adequate supply of antiviral treatment for COVID-19 on site for its residents. The long-term care facility shall provide any resident, who has tested positive for COVID-19 and is symptomatic, antiviral treatment for COVID-19.
b. As used in this section, "long-term care facility" means a nursing home or assisted living residence licensed pursuant to P.L.1971, 41 c.136 (C.26:2H-1 et seq.).
2. This act shall take effect immediately.
STATEMENT
This bill requires long-term care facilities to stock and provide COVID-19 antiviral treatments to their residents.
Under this bill, a long-term care facility will maintain an adequate supply of antiviral treatment for COVID-19 on site for its residents. The long-term care facility will provide any resident, who has tested positive for COVID-19 and is symptomatic, antiviral treatment for COVID-19. The bill defines "long-term care facility" to mean a nursing home or assisted living residence licensed pursuant to P.L.1971, 41 c.136 (C.26:2H-1 et seq.).
